> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Joint Advisory Panel to Review Pain Combo Drug
- URL: https://www.fdaweb.com/joint-advisory-panel-to-review-pain-combo-drug/
- Published: 2020-10-07T12:00:00.000Z
- Updated: 2026-09-14T16:31:40.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5147821

*Federal Register* notice: FDA has announced an 11/2 joint Anesthetic and Analgesic Drug Products Advisory Committee and Drug Safety and Risk Management Advisory Committee meeting. Panel members are scheduled to review an Olas Pharma NDA for Hydexor, a fixed-dose combination oral tablet containing hydrocodone, acetaminophen, and promethazine, indicated for the short-term (not to exceed three days) management of acute post-operative pain severe enough to require an opioid analgesic and the prevention of opioid-induced nausea and vomiting in patients who are at risk for or have a history of nausea and vomiting. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2020-10-07/pdf/2020-22187.pdf?ref=fdaweb.com).